Geodis strengthens pharma capabilities in Europe
29 / 04 / 2024
Copyright: GEODIS – GÜNTER Nils
Geodis has strengthened its temperature-controlled pharmaceutical shipment capabilities in Europe by obtaining IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification for its Copenhagen, Denmark site.
The freight forwarder now has a total of 28 CEIV Pharma certified sites across its global network in the Americas, Asia Pacific, the Middle East and Europe.
Kent Husted, managing director of Geodis Denmark, said: “Denmark is one of the leading countries in the world when it comes to research, development and production of pharmaceuticals. The requirements are strict in terms of quality and selection of suppliers, which is why it made perfect sense to choose the IATA CEIV Pharma Certification for GEODIS Denmark.
“Our most important goal, in general, is to help all our customers by being a good growth partner and creating quality in everything we do. When it comes to pharmaceutical transports, we have a solid global setup that can handle all transports which require temperature control. All employees involved in Pharma transport have received the right training and know what is needed to deliver the products safely to the end users and patients.”
At its site in Copenhagen, Geodis provides a cross dock service with a temperature range of +2°C to +8°C and +15°C to +25°C, complemented by air, ocean and road solutions. The site has easy access to both Copenhagen airport and ocean port facilities.
“Through our global pharma and healthcare network we can offer tailor-made solutions for our customers that comply with the requirements of GDP (Good Distribution Practice) transport. Part of our ambition is to further develop our global end-to-end logistics solutions,” commented Thomas Kraus, president and chief executive of Geodis Europe.
“With last year’s acquisition of trans-o-flex in Germany, we added a wide range of services for time-critical deliveries to our portfolio and offer a fast, reliable and time-definite delivery service, which will be extended to other European countries in the coming months. As a first step in Denmark, with a newly built part of our warehouse solely for our pharma customers, we can ensure that the products are temperature monitored, before they are to be shipped across the world, whether that would be by air, ocean or road transport.”
Geodis has made multiple investments in its pharma operations in recent years.
In April last year, the forwarder said it had gained CEIV Pharma certification for a number of locations across Asia.
And in June last year, Geodis obtained CEIV Pharma certification for its site at Paris-Charles de Gaulle Airport a year after the facility was opened.
Then in October of last year, the company launched a new temperature-controlled facility for the pharma and healthcare sectors at Amsterdam Schiphol Airport.
In 2022-2023 Geodis also worked to gain CEIV Pharma certification at seven of its sites across the Americas.
The IATA CEIV Pharma (Center of Excellence for Independent Validators in Pharmaceutical Logistics) certification ensures that facilities, equipment, operations, and personnel meet the appropriate applicable standards, guidelines and regulations expected of a pharmaceutical manufacturer and logistics provider. It helps organisations and the entire air cargo supply chain optimise pharmaceutical handling, while addressing the industry’s need for more safety, security, compliance, and efficiency.
